All blog posts
Total 43 results for
Showing 12 out of 43 results
14 September 2026
EU Commission’s final Article 102 Guidelines on unilateral conduct: key changes and implications for business
07 November 2025
Gutmann boundary fares case: identifying the boundaries of abuse of dominance
03 March 2025
Latest CRTea podcast now available: Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
23 December 2024
Le Patourel v BT - First competition class action to go to trial fails: key takeaways and implications for the regime
01 November 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
14 October 2024
Highlights from the GCR Live: Competition Litigation conference
07 October 2024
General Court largely rejects Qualcomm's challenge to Commission's predatory pricing decision
04 July 2024
Insights from the latest "pay-for-delay" CJEU judgments: fines on Servier and generics drug manufacturers largely upheld (but not over yet)
21 December 2023
Clarity: Over the Hills and (F)Far Away? The FIFA Football Agents Regulations and their interplay with competition law
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
15 August 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
15 June 2023
Overview of EU and South African regulatory and competition law in the Pharma sector
Showing 12 out of 43 results
View moreKey contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Managing Partner, Competition Regulation and Trade, Asia and Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg
Kristien Geeurickx
Knowledge Counsel, London